-
IntroducedFeb 16, 2023
-
Passed Senate
-
Passed House
-
Signed into Law
An Act specifying an electronic system to ensure that sales of certain products containing pseudoephedrine (PSE) do not exceed limits established under federal law
Last Action See all actions
House • May 09, 2024: Accompanied a study order, see H4634
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on S 1106
Tweets
Whip Lists
Sponsors
Votes
Actions
- May 09, 2024 | House
- Accompanied a study order, see H4634
- Jun 05, 2023 | legislature
- Hearing rescheduled to 06/06/2023 from 10:00 AM-04:00 PM in A-2
- Jun 02, 2023 | legislature
- Location Changed - Hearing scheduled for 06/06/2023 from 10:00 AM-04:00 PM in A-2
- May 23, 2023 | legislature
- Hearing scheduled for 06/06/2023 from 10:00 AM-01:00 PM in A-1
- May 01, 2023 | House
- House concurred
- Apr 27, 2023 | Senate
- Discharged to the committee on Health Care Financing
- Feb 16, 2023 | House
- House concurred
- Feb 16, 2023 | Senate
- Referred to the committee on The Judiciary
Bill Texts
Documents